How much does compounded tirzepatide cost
Detailed Segmentation of the Global GLP-1 Receptor Agonist Market This report breaks down the GLP-1 receptor agonist market into the following segments: 1) Drug Class: Exenatide, Liraglutide, Dulaglutide, Lixisenatide, and other drugs 2) Route of Administration: Parenteral and Oral 3) End Users: Hospitals, Surgical Clinics, and Other Users This comprehensive segmentation offers insights into the variety of therapeutic options, delivery methods, and healthcare settings where GLP-1 receptor agonists are applied, providing a nuanced understanding of the market's structure and potential growth areas
References Cheema AY, Munir M, Mandala A, Aslam F, Acharya U
Call for an urgent rethink of the 'health at every size' concept
8 SUMMIT also demonstrated significant improvements in patient-reported outcomes: at 52 weeks, tirzepatide increased KCCQ-CSS, with a between-group mean difference of 6.9 points, and increased 6-minute walk distance, with a between-group mean difference of 18.3 m
